230 related articles for article (PubMed ID: 27543438)
21. RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing.
Ong AAL; Tan J; Bhadra M; Dezanet C; Patil KM; Chong MS; Kierzek R; Decout JL; Roca X; Chen G
Molecules; 2019 Aug; 24(16):. PubMed ID: 31434312
[TBL] [Abstract][Full Text] [Related]
22. Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA.
Erkelenz S; Poschmann G; Theiss S; Stefanski A; Hillebrand F; Otte M; Stühler K; Schaal H
J Virol; 2013 Mar; 87(5):2721-34. PubMed ID: 23255807
[TBL] [Abstract][Full Text] [Related]
23. Suppression of 5' splice-sites through multiple exonic motifs by hnRNP L.
Loh TJ; Choi N; Moon H; Jang HN; Liu Y; Zhou J; Zheng X; Shen H
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):363-373. PubMed ID: 28119102
[TBL] [Abstract][Full Text] [Related]
24. Use of modified U1 small nuclear RNA for rescue from exon 7 skipping caused by 5'-splice site mutation of human cathepsin A gene.
Yamazaki N; Kanazawa K; Kimura M; Ike H; Shinomiya M; Tanaka S; Shinohara Y; Minakawa N; Itoh K; Takiguchi Y
Gene; 2018 Nov; 677():41-48. PubMed ID: 30010039
[TBL] [Abstract][Full Text] [Related]
25. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
[TBL] [Abstract][Full Text] [Related]
26. Modeling splicing outcome by combining 5'ss strength and splicing regulatory elements.
Müller L; Ptok J; Nisar A; Antemann J; Grothmann R; Hillebrand F; Brillen AL; Ritchie A; Theiss S; Schaal H
Nucleic Acids Res; 2022 Aug; 50(15):8834-8851. PubMed ID: 35947702
[TBL] [Abstract][Full Text] [Related]
27. Correct mRNA processing at a mutant TT splice donor in FANCC ameliorates the clinical phenotype in patients and is enhanced by delivery of suppressor U1 snRNAs.
Hartmann L; Neveling K; Borkens S; Schneider H; Freund M; Grassman E; Theiss S; Wawer A; Burdach S; Auerbach AD; Schindler D; Hanenberg H; Schaal H
Am J Hum Genet; 2010 Oct; 87(4):480-93. PubMed ID: 20869034
[TBL] [Abstract][Full Text] [Related]
28. Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factor.
Liang Q; Lin X; Wu X; Shao Y; Chen C; Dai J; Lu Y; Wu W; Ding Q; Wang X
Hum Mutat; 2022 Feb; 43(2):215-227. PubMed ID: 34882887
[TBL] [Abstract][Full Text] [Related]
29. An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.
Fernandez Alanis E; Pinotti M; Dal Mas A; Balestra D; Cavallari N; Rogalska ME; Bernardi F; Pagani F
Hum Mol Genet; 2012 Jun; 21(11):2389-98. PubMed ID: 22362925
[TBL] [Abstract][Full Text] [Related]
30. Splicing error in E1alpha pyruvate dehydrogenase mRNA caused by novel intronic mutation responsible for lactic acidosis and mental retardation.
Miné M; Brivet M; Touati G; Grabowski P; Abitbol M; Marsac C
J Biol Chem; 2003 Apr; 278(14):11768-72. PubMed ID: 12551913
[TBL] [Abstract][Full Text] [Related]
31. Informational Suppression to Probe RNA:RNA Interactions in the Context of Ribonucleoproteins: U1 and 5' Splice-Site Base-Pairing.
Tan J; Roca X
Methods Mol Biol; 2016; 1421():243-68. PubMed ID: 26965270
[TBL] [Abstract][Full Text] [Related]
32. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
[TBL] [Abstract][Full Text] [Related]
33. An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease.
Daidone V; Gallinaro L; Grazia Cattini M; Pontara E; Bertomoro A; Pagnan A; Casonato A
Haematologica; 2011 Jun; 96(6):881-7. PubMed ID: 21393328
[TBL] [Abstract][Full Text] [Related]
34. The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer.
Palhais B; Dembic M; Sabaratnam R; Nielsen KS; Doktor TK; Bruun GH; Andresen BS
Mol Genet Metab; 2016 Nov; 119(3):258-269. PubMed ID: 27595546
[TBL] [Abstract][Full Text] [Related]
35. A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.
Madsen JM; Stoltzfus CM
Retrovirology; 2006 Feb; 3():10. PubMed ID: 16457729
[TBL] [Abstract][Full Text] [Related]
36. A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene.
Castaman G; Novella E; Castiglia E; Eikenboom JC; Rodeghiero F
Thromb Res; 2002 Jan; 105(2):135-8. PubMed ID: 11958803
[TBL] [Abstract][Full Text] [Related]
37. Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses.
Holla ØL; Nakken S; Mattingsdal M; Ranheim T; Berge KE; Defesche JC; Leren TP
Mol Genet Metab; 2009 Apr; 96(4):245-52. PubMed ID: 19208450
[TBL] [Abstract][Full Text] [Related]
38. Quantitative Activity Profile and Context Dependence of All Human 5' Splice Sites.
Wong MS; Kinney JB; Krainer AR
Mol Cell; 2018 Sep; 71(6):1012-1026.e3. PubMed ID: 30174293
[TBL] [Abstract][Full Text] [Related]
39. Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation.
Schwarze U; Starman BJ; Byers PH
Am J Hum Genet; 1999 Aug; 65(2):336-44. PubMed ID: 10417276
[TBL] [Abstract][Full Text] [Related]
40. Splicing proofreading at 5' splice sites by ATPase Prp28p.
Yang F; Wang XY; Zhang ZM; Pu J; Fan YJ; Zhou J; Query CC; Xu YZ
Nucleic Acids Res; 2013 Apr; 41(8):4660-70. PubMed ID: 23462954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
